Breakthrough technology that identifies molecular markers in early lung cancer Researchers in the University of Liverpool are suffering from a breakthrough technology that identifies molecular markers in early lung tumor. The new technology, developed in collaboration with SEQUENOM, designers of genetic analysis items, and Methexis Genomics, runs on the DNA analysis technique known as methylation profiling to identify cells in the lung that will probably become cancerous http://lady-era.net read more .
The higher the glow, the even more of the biomarker exists. However, if the quantity of biomarker is as well little, the fluorescent light can be as well faint to become detected, placing the limit of recognition. A significant goal in immunoassay analysis is to boost the detection limit. The Princeton researchers tackled this limitation through the use of nanotechnology to amplify the faint fluorescence from an example greatly. By fashioning cup and gold structures therefore small they could just be seen with a robust electron microscope, the researchers could actually drastically raise the fluorescence signal in comparison to conventional immunoassays, resulting in a 3-million-fold improvement in the limit of recognition.